Neurocrine Biosciences
NBIX
#1482
Rank
ยฃ9.10 B
Marketcap
ยฃ90.18
Share price
-1.75%
Change (1 day)
-3.01%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of June 2024 : ยฃ1.91 B

According to Neurocrine Biosciences 's latest financial reports the company has ยฃ1.91 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$ยฃ1.75 B24.11%
2022-12-31$ยฃ1.41 B39.04%
2021-12-31$ยฃ1.01 B23.07%
2020-12-31$ยฃ0.82 B71.89%
2019-12-31$ยฃ0.47 B27.37%
2018-12-31$ยฃ0.37 B36.84%
2017-12-31$ยฃ0.27 B7.9%
2016-12-31$ยฃ0.25 B-10.81%
2015-12-31$ยฃ0.28 B113.43%
2014-12-31$ยฃ0.13 B83.88%
2013-12-31$ยฃ72.9 M-23.63%
2012-12-31$ยฃ95.46 M146.97%
2011-12-31$ยฃ38.65 M207.42%
2010-12-31$ยฃ12.57 M410.46%
2009-12-31$ยฃ2.46 M-90.34%
2008-12-31$ยฃ25.5 M-57.1%
2007-12-31$ยฃ59.44 M-63%
2006-12-31$ยฃ0.16 B-28.98%
2005-12-31$ยฃ0.22 B10.18%
2004-12-31$ยฃ0.20 B-6.9%
2003-12-31$ยฃ0.22 B57.69%
2002-12-31$ยฃ0.13 B-34.67%
2001-12-31$ยฃ0.21 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ยฃ1.51 B-20.84%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.43 B 288.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ1.2 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.38 B 443.42%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.19 B 171.84%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ67.03 B 3,406.10%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.36 B-80.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ27.74 M-101.45%๐Ÿ‡บ๐Ÿ‡ธ USA